Home > Insider Trading > Filing (0001209191-18-045799)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885978	U S Physical Therapy Inc	USPH	Services-Health Services (8000)	760364866

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1270356	J Christopher Reading	1300 W. Sam Houston Pkwy S. Suite 300 Houston TX 77042	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-08-06	781	$116.58	77,686	No	4	S	Direct
Common Stock	Disposition	2018-08-07	451	$115.78	77,235	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.50 - $117.35, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Includes 41,454 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022.
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.40 - $116.50, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.